Teva Financial Statements From 2010 to 2026

Teva Pharma Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 27.3 B 40.7 B 48.5 B Very volatile Short and Long Term Debt Total 9.8 B 17.4 B 19 B Slightly volatile Other Current Liabilities 9.6 B 9.1 B 8 B Pretty Stable Total Current Liabilities 6.9 B 13.5 B 12.3 B Very volatile Total Stockholder Equity 9.8 B 7.9 B 15.2 B Slightly volatile Property Plant And Equipment Net 3.3 B 4.4 B 5.9 B Very volatile Net Debt 8.4 B 13.8 B 16.7 B Pretty Stable Cash 3.7 B 3.6 B 2.4 B Slightly volatile Non Current Assets Total 19.3 B 26.8 B 35.4 B Very volatile Non Currrent Assets Other 647.9 M 405 M 903.8 M Slightly volatile Cash And Short Term Investments 3.7 B 3.6 B 2.4 B Slightly volatile Net Receivables 3 B 3.7 B 4.7 B Pretty Stable Common Stock Shares Outstanding 801.5 M 1.2 B 964.7 M Slightly volatile Liabilities And Stockholders Equity 27.3 B 40.7 B 48.5 B Very volatile Non Current Liabilities Total 10.4 B 19.4 B 20.3 B Slightly volatile Inventory 2.4 B 3.2 B 4 B Pretty Stable Other Current Assets 3.7 B 3.5 B 2.2 B Slightly volatile Other Stockholder Equity 25.2 B 24 B 18.1 B Slightly volatile Total Liabilities 17.3 B 32.8 B 32.7 B Slightly volatile Total Current Assets 8 B 13.9 B 13 B Very volatile Short Term Debt 1.3 B 1.8 B 2.2 B Pretty Stable Intangible Assets 4.6 B 3.8 B 8.4 B Pretty Stable Accounts Payable 1.6 B 2.5 B 2.1 B Very volatile Short Term Investments 1.2 B 1.1 B 537.9 M Slightly volatile Common Stock 55.4 M 52.2 M 58.1 M Slightly volatile Other Liabilities 5.3 B 5.1 B 3.4 B Slightly volatile Long Term Debt 12.9 B 15 B 16.9 B Slightly volatile Property Plant Equipment 4.8 B 7.1 B 6.1 B Pretty Stable Current Deferred Revenue 3.1 B 5.7 B 4.2 B Slightly volatile Good Will 17.7 B 16 B 20.1 B Very volatile Common Stock Total Equity 53.7 M 65.5 M 53.5 M Slightly volatile Property Plant And Equipment Gross 6 B 9.2 B 6.9 B Slightly volatile Long Term Investments 52.2 M 54.9 M 190.6 M Slightly volatile Short and Long Term Debt 2.4 B 1.8 B 4.6 B Slightly volatile Deferred Long Term Liabilities 824.2 M 867.6 M 1.5 B Pretty Stable Long Term Debt Total 26.3 B 26.1 B 19.3 B Slightly volatile Capital Surpluse 27.4 B 31.7 B 23.8 B Slightly volatile Preferred Stock Total Equity 3.9 B 4.2 B 3.6 B Slightly volatile Noncontrolling Interest In Consolidated Entity 890.4 M 869.4 M 1.2 B Slightly volatile Additional Paid In Capital 18.8 B 21.1 B 23.1 B Slightly volatile Net Invested Capital 27 B 24.7 B 38.5 B Slightly volatile Capital Stock 62.7 M 66.7 M 57.4 M Slightly volatile Deferred Long Term Asset Charges 414.7 M 443.9 M 381.6 M Slightly volatile Capital Lease Obligations 295.2 M 288 M 399.6 M Slightly volatile
Teva Pharma Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 724.7 M 1 B 1.3 B Very volatile Interest Expense 961.8 M 916 M 707.3 M Slightly volatile Total Revenue 10 B 17.3 B 16.8 B Very volatile Gross Profit 5 B 8.9 B 8.5 B Pretty Stable Other Operating Expenses 8.5 B 15.1 B 14.8 B Pretty Stable Cost Of Revenue 4.9 B 8.3 B 8.4 B Very volatile Total Operating Expenses 3.6 B 6.8 B 6.4 B Slightly volatile Research Development 861.5 M 1 B 1.2 B Very volatile Selling General Administrative 1.2 B 1.3 B 1.2 B Slightly volatile Selling And Marketing Expenses 3.1 B 2.7 B 2.9 B Pretty Stable Non Recurring 5.6 B 5.3 B 3.9 B Slightly volatile Interest Income 714.6 M 948.8 M 598.3 M Slightly volatile Preferred Stock And Other Adjustments 203.6 M 224.1 M 250 M Slightly volatile Reconciled Depreciation 1.2 B 1 B 1.7 B Slightly volatile
Teva Pharma Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 85.6 M 157 M 102.3 M Slightly volatile Begin Period Cash Flow 3.5 B 3.3 B 2.2 B Slightly volatile Depreciation 788.3 M 1 B 1.3 B Very volatile Other Non Cash Items 1.6 B 1.1 B 2.9 B Very volatile Dividends Paid 56.8 M 59.8 M 484.1 M Slightly volatile Capital Expenditures 490 M 501 M 656.4 M Slightly volatile Total Cash From Operating Activities 1.9 B 1.6 B 2.6 B Slightly volatile End Period Cash Flow 3.7 B 3.6 B 2.4 B Slightly volatile Change To Netincome 1.2 B 1.2 B 2.8 B Very volatile Exchange Rate Changes 43.2 M 48.6 M 53 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 1.84 1.9408 6.2611 Slightly volatile Dividend Yield 0.0041 0.0043 0.0158 Slightly volatile PTB Ratio 4.35 4.5827 10.8566 Slightly volatile Days Sales Outstanding 130 72.4825 105 Slightly volatile Book Value Per Share 8.3 6.9132 16.5017 Slightly volatile Operating Cash Flow Per Share 1.65 2.7066 2.8224 Slightly volatile Stock Based Compensation To Revenue 0.0046 0.0067 0.0058 Slightly volatile Capex To Depreciation 0.48 0.5 0.5791 Slightly volatile PB Ratio 4.35 4.5827 10.8566 Slightly volatile EV To Sales 2.55 2.6811 7.203 Slightly volatile Inventory Turnover 1.67 2.846 2.1262 Slightly volatile Days Of Inventory On Hand 196 128 174 Slightly volatile Payables Turnover 2.81 3.5747 3.9915 Pretty Stable Sales General And Administrative To Revenue 0.0511 0.0632 0.064 Slightly volatile Research And Ddevelopement To Revenue 0.0515 0.0587 0.0663 Slightly volatile Capex To Revenue 0.0276 0.029 0.0391 Slightly volatile Cash Per Share 3.26 3.1063 2.3956 Pretty Stable POCF Ratio 11.11 11.6991 50.9436 Slightly volatile Capex To Operating Cash Flow 0.18 0.175 0.421 Slightly volatile Days Payables Outstanding 136 102 98.1029 Pretty Stable EV To Operating Cash Flow 30.88 16.1613 62.9393 Slightly volatile Intangibles To Total Assets 0.28 0.4854 0.5201 Very volatile Current Ratio 1.65 1.0364 1.1533 Pretty Stable Receivables Turnover 2.58 5.0357 3.6161 Slightly volatile Graham Number 11.08 12.96 18.912 Slightly volatile Shareholders Equity Per Share 8.11 6.9097 15.9516 Slightly volatile Debt To Equity 2.31 2.1975 1.6757 Slightly volatile Capex Per Share 0.42 0.4736 0.6825 Slightly volatile Revenue Per Share 17.13 16.3155 17.5876 Pretty Stable Interest Debt Per Share 16.87 16.0669 19.7089 Pretty Stable Debt To Assets 0.27 0.4266 0.3794 Slightly volatile Short Term Coverage Ratios 0.96 1.7025 1.2113 Pretty Stable Operating Cycle 325 201 278 Slightly volatile Price Book Value Ratio 4.35 4.5827 10.8566 Slightly volatile Days Of Payables Outstanding 136 102 98.1029 Pretty Stable Price To Operating Cash Flows Ratio 11.11 11.6991 50.9436 Slightly volatile Company Equity Multiplier 5.41 5.1515 3.9539 Slightly volatile Long Term Debt To Capitalization 0.69 0.6588 0.534 Slightly volatile Total Debt To Capitalization 0.37 0.6873 0.5496 Slightly volatile Debt Equity Ratio 2.31 2.1975 1.6757 Slightly volatile Quick Ratio 1.11 0.8002 0.7976 Pretty Stable Dividend Paid And Capex Coverage Ratio 6.0 5.7146 2.6848 Slightly volatile Net Income Per E B T 0.62 1.1397 0.8398 Pretty Stable Cash Ratio 0.28 0.2643 0.2156 Very volatile Cash Conversion Cycle 93.69 98.6243 197 Slightly volatile Operating Cash Flow Sales Ratio 0.12 0.1659 0.1416 Slightly volatile Days Of Inventory Outstanding 196 128 174 Slightly volatile Days Of Sales Outstanding 130 72.4825 105 Slightly volatile Cash Flow Coverage Ratios 0.29 0.1783 0.1829 Slightly volatile Price To Book Ratio 4.35 4.5827 10.8566 Slightly volatile Fixed Asset Turnover 3.45 4.2209 2.9273 Pretty Stable Capital Expenditure Coverage Ratio 6.0 5.7146 3.8616 Very volatile Price Cash Flow Ratio 11.11 11.6991 50.9436 Slightly volatile Debt Ratio 0.27 0.4266 0.3794 Slightly volatile Cash Flow To Debt Ratio 0.29 0.1783 0.1829 Slightly volatile Price Sales Ratio 1.84 1.9408 6.2611 Slightly volatile Asset Turnover 0.63 0.4584 0.393 Very volatile Gross Profit Margin 0.38 0.5156 0.4844 Pretty Stable Price Fair Value 4.35 4.5827 10.8566 Slightly volatile
Teva Pharma Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 13.9 B 22.7 B 24.8 B Slightly volatile Enterprise Value 34.2 B 32.5 B 41.5 B Slightly volatile

Teva Fundamental Market Drivers

Teva Upcoming Events

About Teva Pharma Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:

How To Invest In Teva Details

Is Teva Stock a good investment? Details

What is Teva Pharma's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details